Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-28

Clinical Trial Update: Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition [NA]

View source ↗

Summary

Clinical trial update on using a taurolidine catheter lock to prevent infections in cancer patients requiring parenteral nutrition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taurolidine lock solution (taurolidine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cancer, Infection | NA | Status: UNKNOWN